Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial

Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts 02115.

Thrombolysis of acute pulmonary embolism can be accomplished more rapidly and safely with 100 mg of recombinant human tissue-type plasminogen activator (rt-PA) (Activase) than with a conventional dose of urokinase (Abbokinase) given as a 4,400-U/kg bolus dose, followed by 4,400 U/kg per h for 24 h. To determine the effects of a more concentrated urokinase dose administered over a shorter time course, this trial enrolled 90 patients with baseline perfusion lung scans and angiographically documented pulmonary embolism. They were randomized to receive either 100 mg/2 h of rt-PA or a novel dosing regimen of urokinase: 3 million U/2 h with the initial 1 million U given as a bolus injection over 10 min. Both drugs were delivered through a peripheral vein. To assess efficacy after initiation of therapy, repeat pulmonary angiograms at 2 h were performed in 87 patients and then graded in a blinded manner by a panel of six investigators. Of the 42 patients allocated to rt-PA therapy, 79% showed angiographic improvement at 2 h, compared with 67% of the 45 patients randomized to urokinase therapy (95% confidence interval for the difference in these proportions [rt-PA minus urokinase] is -6.6% to 30.4%; p = 0.11). The mean change in perfusion lung scans between baseline and 24 h was similar for both treatments. Three patients (two treated with rt-PA and one with urokinase) had an intracranial hemorrhage, which was fatal in one. The results indicate that a 2-h regimen of rt-PA and a new dosing regimen of urokinase exhibit similar efficacy and safety for treatment of acute pulmonary embolism.

This article has been cited by other articles:

				C. Kearon, E. A. Akl, A. J. Comerota, P. Prandoni, H. Bounameaux, S. Z. Goldhaber, M. E. Nelson, P. S. Wells, M. K. Gould, F. Dentali, et al. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest, February 1, 2012; 141(2_suppl): e419S - e494S. [Abstract] [Full Text] [PDF]

				L. Wang, Z. Gong, J. Jiang, W. Xu, Q. Duan, J. Liu, and C. Qin Confusion of Wide Thrombolytic Time Window for Acute Pulmonary Embolism: Mass Spectrographic Analysis for Thrombus Proteins Am. J. Respir. Crit. Care Med., July 1, 2011; 184(1): 145 - 146. [Full Text] [PDF]

				C. Wang, Z. Zhai, Y. Yang, Q. Wu, Z. Cheng, L. Liang, H. Dai, K. Huang, W. Lu, Z. Zhang, et al. Efficacy and Safety of Low Dose Recombinant Tissue-Type Plasminogen Activator for the Treatment of Acute Pulmonary Thromboembolism: A Randomized, Multicenter, Controlled Trial Chest, February 1, 2010; 137(2): 254 - 262. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, P. Pruszczyk, F. Bengel, A. J.B. Brady, D. Ferreira, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur. Heart J., September 2, 2008; 29(18): 2276 - 2315. [Full Text] [PDF]

				C. Kearon, S. R. Kahn, G. Agnelli, S. Goldhaber, G. E. Raskob, and A. J. Comerota Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 454S - 545S. [Abstract] [Full Text] [PDF]

				C. Engelke, E. J. Rummeny, and K. Marten Acute Pulmonary Embolism on MDCT of the Chest: Prediction of Cor Pulmonale and Short-Term Patient Survival from Morphologic Embolus Burden. Am. J. Roentgenol., May 1, 2006; 186(5): 1265 - 1271. [Abstract] [Full Text] [PDF]

				C. Engelke, E. J. Rummeny, and K. Marten Pulmonary Embolism at Multi-Detector Row CT of Chest: One-year Survival of Treated and Untreated Patients Radiology, May 1, 2006; 239(2): 563 - 575. [Abstract] [Full Text] [PDF]

				A Sheth, P Cullinan, V Vachharajani, and S A Conrad Bolus thrombolytic infusion during prolonged refractory cardiac arrest of undiagnosed cause Emerg. Med. J., March 1, 2006; 23(3): e19 - e19. [Abstract] [Full Text] [PDF]

				T. Capstick and M. T. Henry Efficacy of thrombolytic agents in the treatment of pulmonary embolism Eur. Respir. J., November 1, 2005; 26(5): 864 - 874. [Abstract] [Full Text] [PDF]

				T Harris and S Meek When should we thrombolyse patients with pulmonary embolism? A systematic review of the literature Emerg. Med. J., November 1, 2005; 22(11): 766 - 771. [Abstract] [Full Text] [PDF]

				M. McGuire and P. P. Dobesh Therapeutic Update on the Prevention and Treatment of Venous Thromboembolism Journal of Pharmacy Practice, October 1, 2004; 17(5): 289 - 307. [Abstract] [PDF]

				H. Tajima, S. Murata, T. Kumazaki, K. Nakazawa, Y. Abe, Y. Komada, P. Niggemann, M. Takayama, K. Tanaka, and T. Takano Hybrid Treatment of Acute Massive Pulmonary Thromboembolism: Mechanical Fragmentation with a Modified Rotating Pigtail Catheter, Local Fibrinolytic Therapy, and Clot Aspiration Followed by Systemic Fibrinolytic Therapy Am. J. Roentgenol., September 1, 2004; 183(3): 589 - 595. [Abstract] [Full Text] [PDF]

				J. W. Kreit The Impact of Right Ventricular Dysfunction on the Prognosis and Therapy of Normotensive Patients With Pulmonary Embolism Chest, April 1, 2004; 125(4): 1539 - 1545. [Abstract] [Full Text] [PDF]

				G. Thabut, D. Thabut, R. P. Myers, B. Bernard-Chabert, R. Marrash-Chahla, H. Mal, and M. Fournier Thrombolytic therapy of pulmonary embolism: A meta-analysis J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1660 - 1667. [Abstract] [Full Text] [PDF]

				K. E. Wood Major Pulmonary Embolism : Review of a Pathophysiologic Approach to the Golden Hour of Hemodynamically Significant Pulmonary Embolism Chest, March 1, 2002; 121(3): 877 - 905. [Abstract] [Full Text] [PDF]

				S.Z. Goldhaber Modern treatment of pulmonary embolism Eur. Respir. J., February 1, 2002; 19(35_suppl): 22S - 27s. [Abstract] [Full Text] [PDF]

				Y. Misawa, K. Fuse, T. Yamaguchi, T. Saito, and H. Konishi Mechanical circulatory assist for pulmonary embolism Perfusion, December 1, 2000; 15(6): 527 - 529. [Abstract] [PDF]

				Guidelines on diagnosis and management of acute pulmonary embolism Eur. Heart J., August 2, 2000; 21(16): 1301 - 1336. [PDF]

				T. Schmitz-Rode, U. Janssens, S. H. Duda, C. M. Erley, and R. W. Gunther Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter J. Am. Coll. Cardiol., August 1, 2000; 36(2): 375 - 380. [Abstract] [Full Text] [PDF]

				G. Sharma, E. D Folland, K. M McIntyre, and A. A Sasahara Long-term benefit of thrombolytic therapy in patients with pulmonary embolism Vascular Medicine, May 1, 2000; 5(2): 91 - 95. [Abstract] [PDF]

				S. Z Goldhaber A contemporary approach to thrombolytic therapy for pulmonary embolism Vascular Medicine, May 1, 2000; 5(2): 115 - 123. [Abstract] [PDF]

				M.D. Thomas, A. Chauhan, and R.S. More Pulmonary embolism--an update on thrombolytic therapy QJM, May 1, 2000; 93(5): 261 - 267. [Full Text] [PDF]

				S. M. Arcasoy and J. W. Kreit Thrombolytic Therapy of Pulmonary Embolism: A Comprehensive Review of Current Evidence Chest, June 1, 1999; 115(6): 1695 - 1707. [Abstract] [Full Text] [PDF]

				J. E. Dalen, J. S. Alpert, and J. Hirsh Thrombolytic Therapy for Pulmonary Embolism: Is It Effective? Is It Safe? When Is It Indicated? Arch Intern Med, December 8, 1997; 157(22): 2550 - 2556. [Abstract] [PDF]

				W. Burger, G.-D. Kneissl, A. Hartmann, R. Bauersachs, V. Doring, U. Spengler, G. Neumann, and K. W. Rothe Successful Thrombolysis After Prosthetic Pulmonary Valve Obstruction Under Aspirin Monotherapy Ann. Thorac. Surg., July 1, 1997; 64(1): 255 - 257. [Abstract] [Full Text]

				A. S. Ward, S. K. Andaz, and S. Bygrave Peripheral Thrombolysis With Tissue Plasminogen Activator: Results of Two Treatment Regimens Arch Surg, August 1, 1994; 129(8): 861 - 865. [Abstract] [PDF]

				L. A. Witty, A. Krichman, and V. F. Tapson Thrombolytic Therapy for Venous Thromboembolism: Utilization by Practicing Pulmonologists Arch Intern Med, July 25, 1994; 154(14): 1601 - 1604. [Abstract] [PDF]